Uric Acid Meter Market Size, Trends

Uric Acid Meter Market Overview

The Uric Acid Meter Market size was valued at USD 81.61 million in 2024 and is expected to reach USD 109.02 million by 2033, growing at a CAGR of 3.3% from 2025 to 2033.

The uric acid meter market has witnessed significant expansion in recent years due to increasing global prevalence of hyperuricemia and gout. According to the Global Burden of Disease Study, over 41 million people globally are affected by gout, a condition that requires regular uric acid monitoring. Uric acid meters provide point-of-care testing, delivering accurate results within 30–60 seconds, supporting timely medical interventions. In 2023, more than 60 million units of uric acid test strips were sold globally, reflecting a growing consumer demand for home diagnostics.

The market is increasingly driven by the aging population and growing cases of metabolic syndrome. A study in China reported that 13.3% of adults suffer from hyperuricemia, prompting a surge in device adoption. Technological improvements such as Bluetooth-enabled meters and data syncing capabilities have raised product usage in both clinical and household applications.

Moreover, integration with mobile apps has expanded usability, with over 250,000 users in Asia-Pacific currently tracking uric acid levels via connected meters. Disposable test strips attached to compact, handheld meters now command over 70% of the home-use market. With regulatory approvals rising, particularly in developing regions, the uric acid meter market is rapidly becoming a mainstream component of chronic disease management solutions.

Key Findings

DRIVER: Increasing incidence of gout and hyperuricemia, especially among aging populations and individuals with metabolic disorders.

COUNTRY/REGION: China leads with the highest demand, accounting for more than 34% of total device sales globally in 2023.

SEGMENT: Household application segment dominates with over 58% market share, driven by growing patient preference for self-monitoring tools.

Uric Acid Meter Market Trends

Several key trends are shaping the uric acid meter market in 2024. The first major trend is the rise in self-monitoring and point-of-care diagnostics, largely driven by increased public awareness of chronic diseases. In the U.S., more than 8.3 million adults have gout, necessitating regular uric acid monitoring. The availability of affordable, easy-to-use uric acid meters has led to the shipment of more than 15 million units across North America in 2023 alone. Another trend is the technological evolution of portable devices. Bluetooth-enabled uric acid meters now account for over 40% of new product sales. These smart devices can sync with mobile apps and healthcare databases, helping physicians remotely monitor uric acid levels. Over 120 mobile health apps now support uric acid integration, particularly in Japan and South Korea. The reduction in meter size and power consumption has enabled the expansion of compact rechargeable models. In Europe, compact charging uric acid meters saw a 22% increase in adoption rate from 2022 to 2023. Simultaneously, battery-powered variants continue to dominate rural and developing areas, with over 67% of users in African and South Asian markets preferring battery-based meters due to limited access to electricity. Environmental concerns are also influencing product development. More than 18 manufacturers have launched recyclable or biodegradable test strips in the past year. These sustainable product lines are especially gaining traction in Germany and Nordic countries, where over 11% of consumers expressed willingness to pay extra for eco-friendly meters.

Uric Acid Meter Market Dynamics

Market dynamics refer to the set of forces—internal and external—that influence the behavior, structure, and performance of a market over time. In the context of the uric acid meter market, dynamics encompass the drivers that fuel demand, the restraints that hinder growth, the opportunities that could be leveraged for expansion, and the challenges that manufacturers and stakeholders must overcome.

DRIVER

Rising prevalence of hyperuricemia and gout worldwide.

Increased diagnosis of uric acid-related disorders such as gout and kidney stones is a primary driver of market growth. According to the CDC, over 3.9% of the U.S. population has elevated uric acid levels. A study in India found that 25% of urban adults aged 40–60 had hyperuricemia. The disease burden is prompting governments and healthcare providers to advocate regular uric acid screening. Hospitals in Japan reported a 28% rise in demand for uric acid testing devices in outpatient departments in 2023. The accessibility of portable meters is further encouraging individuals to self-monitor, with over 9 million self-testing users registered globally.

RESTRAINT

Limited awareness in rural and low-income regions.

Despite rising availability, adoption remains limited in rural areas of Africa, South Asia, and Latin America. Less than 20% of rural patients in these areas are aware of uric acid testing tools. In Nigeria, a study showed only 13% of gout patients had access to uric acid monitoring devices. Additionally, inconsistent availability of test strips and lack of reimbursement policies hinder product adoption. Distribution channel constraints also restrict timely restocking of consumables, affecting patient adherence to regular monitoring.

OPPORTUNITY

Expansion of telemedicine and remote monitoring systems.

The growth of telehealth platforms presents a significant opportunity. Uric acid meters integrated with wireless transmission capabilities allow real-time data sharing with healthcare providers. In China, over 42,000 remote patients monitored uric acid levels via telemedicine in 2023. Insurance companies in the U.S. and Germany have started reimbursing connected uric acid meters under chronic disease plans. In India, partnerships between e-health startups and device manufacturers led to 12,000+ devices being deployed in tier 2 and 3 cities.

CHALLENGE

Accuracy issues in low-cost uric acid meters.

Budget uric acid meters often face criticism regarding accuracy and calibration. Clinical trials conducted across 5 hospitals in Brazil showed that 38% of low-cost meters had a deviation greater than ±20 µmol/L from lab results. Additionally, counterfeit test strips are prevalent in several markets, particularly in Southeast Asia. These inconsistencies reduce user trust and can lead to incorrect diagnosis or overmedication. The absence of globally harmonized standards for uric acid meter calibration further exacerbates reliability concerns.

Uric Acid Meter Market Segmentation

The uric acid meter market is segmented by type and application, targeting multiple user groups across healthcare and homecare sectors. Based on type, devices are categorized into Battery Model and Charging Model. On the basis of application, they are classified into Hospital, Clinic, and Household segments.

By Type

Battery Model: Battery-powered uric acid meters are widely used in areas with limited infrastructure. In 2023, they represented 62% of total device sales globally. Over 4.3 million units were sold in low and middle-income countries, notably in Africa, India, and Indonesia. These meters are cost-effective and lightweight, making them ideal for community health workers. They typically use AAA or CR2032 batteries, offering 250–300 readings per battery cycle.
Charging Model: Rechargeable meters, typically USB-powered, have gained popularity in urban and developed regions. In Europe, charging models accounted for 41% of new uric acid meter installations in 2023. These meters support long-term usage with 500+ test cycles per charge. Hospitals and high-volume clinics favor these models for their durability and sustainability. Charging models are also equipped with advanced features like LCD touchscreens, multi-user memory storage, and connectivity via Wi-Fi or Bluetooth.

By Application

Hospital: Hospitals represent a key segment in the uric acid meter market, primarily utilizing the devices for point-of-care diagnostics and bedside monitoring. In 2023, hospitals accounted for approximately 18% of total uric acid meter usage globally.
Clinic: Clinics, particularly outpatient care and specialty practices, are another important application area. In 2023, clinics held about 24% of the market share. Primary care clinics use uric acid meters to screen at-risk patients with symptoms like joint pain and kidney dysfunction.
Household: The household segment is the largest and fastest-growing application category, accounting for over 58% of the uric acid meter market in 2023. The rising prevalence of hyperuricemia, particularly among middle-aged and elderly populations, has led to greater adoption of home-use meters.

Regional Outlook for the Uric Acid Meter Market

The uric acid meter market shows diversified performance across key regions. Regional outlook in the uric acid meter market refers to the comparative analysis of how the market performs across various geographical regions, including North America, Europe, Asia-Pacific, and the Middle East & Africa. This outlook evaluates regional differences in disease prevalence, consumer behavior, infrastructure availability, government policies, and adoption rates of uric acid meters.

North America

In 2023, the U.S. recorded more than 8.3 million gout cases, with uric acid meters used in over 65% of diagnosed patients. Canada saw the distribution of over 720,000 home-use meters, driven by government reimbursements and chronic disease education programs. Urban adoption rates exceed 78%, while rural areas still lag at 34% due to accessibility issues.

Europe

Germany and the UK lead the regional market, accounting for 1.4 million combined unit sales in 2023. The German Diabetes Association has started recommending hybrid uric acid-glucose meters for elderly patients. France saw a 19% increase in uric acid meter prescriptions in primary care settings, supported by national digital health initiatives.

Asia-Pacific

China dominates the global landscape, with over 6 million units sold in 2023 alone. Urban hospitals in Shanghai, Beijing, and Shenzhen collectively purchased more than 1.2 million meters. India follows, with approximately 2.3 million active household users. South Korea and Japan are seeing rapid uptake of smart meters, particularly among elderly patients.

Middle East & Africa

Market penetration remains low, but growth is emerging. Saudi Arabia distributed 150,000 units under a national metabolic health initiative. In Sub-Saharan Africa, South Africa accounted for 60% of all uric acid meter imports, with 300,000 devices sold in 2023. However, access to test strips remains uneven.

List of Top Uric Acid Meter Companies

Cofoe
Sinocare
Min Kang
Benecheck
Haiyuan Medical

Cofoe: In 2023, Cofoe led the market with over 3.1 million units sold, particularly excelling in Asia-Pacific. Their models support dual testing (glucose and uric acid) and have Bluetooth connectivity.

Sinocare: Ranked second, Sinocare distributed more than 2.5 million devices globally in 2023. Known for its affordable, compact meters and test strips, Sinocare holds a significant market share in both hospital and household segments.

Investment Analysis and Opportunities

Investment in the uric acid meter market is increasingly directed toward innovation, distribution expansion, and strategic partnerships. In 2023, over $150 million was funneled into uric acid monitoring startups, mainly in Asia-Pacific and North America. Private equity firms are targeting diagnostic device manufacturers focusing on telemedicine integration and AI-enabled features. More than 27 merger and acquisition activities were recorded between 2022 and 2024, highlighting investor confidence in this niche market. Home healthcare companies and retail pharmacy chains are partnering with uric acid meter manufacturers to expand consumer outreach. In the U.S., 3,200+ retail outlets began stocking uric acid meters in 2023, up from 2,100 in 2021. Similarly, online sales platforms have enabled 23% year-over-year growth in direct-to-consumer shipments, especially in emerging markets. Government healthcare budgets are also influencing investment strategies. India’s health ministry allocated INR 65 crore in 2023 for non-communicable disease monitoring, including uric acid testing devices. Several state governments in Brazil and Argentina announced subsidies on uric acid meters, increasing procurement by over 170,000 units combined. Investments in R&D are also growing, with more than 19 companies actively working on multi-parameter testing platforms. These devices aim to combine cholesterol, uric acid, and glucose analysis into a single unit, expected to improve patient adherence and reduce long-term costs. Early clinical trials in Germany and Japan show a 98.7% accuracy rate for these devices.

New Product Development

Product innovation in the uric acid meter market is focused on improving usability, speed, and connectivity. In 2023, Cofoe launched a new model with dual-mode testing and results delivered in under 20 seconds, setting a new benchmark. Sinocare followed with a multi-user model suitable for clinics, supporting memory storage for 20 patients simultaneously. Other manufacturers introduced AI-powered meters capable of detecting trends and issuing health alerts. These systems processed over 1.5 million patient data entries in their pilot phases, with accuracy deviations of less than ±10 µmol/L. In South Korea, a leading startup developed a device with voice-guided instructions, enabling visually impaired users to self-test. Environmental innovation is also accelerating. Benecheck introduced biodegradable uric acid test strips certified for composting under ISO 14855. Initial adoption in Scandinavian countries resulted in 130,000 strips sold in just 4 months. Additionally, Haiyuan Medical launched solar-powered meter models for field hospitals and mobile clinics in Africa, generating interest from NGOs and government health agencies. Integration with wearable technologies is another exciting frontier. Smartwatches with uric acid monitoring capabilities are currently undergoing trials in Singapore and Israel. These devices are projected to enter the consumer market by Q1 2025, with potential to revolutionize continuous uric acid monitoring for at-risk populations.

Five Recent Developments

Cofoe launched a Bluetooth-enabled meter with under-20s test result speed in Q3 2023.
Sinocare partnered with Apollo Clinics in India to deploy 15,000 units in urban outpatient centers.
Min Kang introduced a rechargeable model with multi-language support in May 2023.
Benecheck filed a patent for AI-integrated uric acid meters in July 2023.
Haiyuan Medical began pilot programs in Kenya using solar-powered uric acid meters in mobile clinics.

Report Coverage of Uric Acid Meter Market

This report on the uric acid meter market provides a comprehensive analysis covering all aspects of the value chain from product development to end-user application. It focuses on the dynamics of demand across hospitals, clinics, and household users, using quantified data on adoption rates, distribution volumes, and regional splits. The scope includes segmentation by device type—battery and charging models—and their respective performance across geographies. Coverage extends to market trends such as the emergence of eco-friendly and AI-enabled meters, and evolving consumer behaviors including self-testing, mobile tracking, and hybrid disease management. The report incorporates factual comparisons of unit shipments, error margins in accuracy, and geographic expansion strategies. It further profiles major companies such as Cofoe and Sinocare based on device specifications, market penetration, distribution partnerships, and innovation pipelines. Additionally, the report evaluates investment flows, product launches, government procurement policies, and new reimbursement frameworks emerging globally.